Schubert EA

ORCID: 0000-0002-2533-0001 · 2 papers in corpus

2023

Medicinal cannabis for Australian patients with chronic refractory pain including arthritis.

British journal of pain ·doi:10.1177/20494637221147115

ObjectivesTo examine the tolerability and effectiveness of medicinal cannabis prescribed to patients for chronic, refractory pain, with a subset analysis on arthritis.MethodsThis was an interim analysis of the CA Clinics Observational Study…

2023

The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians ·doi:10.1177/87551225231180796

Background: Anxiety is a condition for which current treatments are often limited by adverse events (AEs). Components of medicinal cannabis, cannabidiol (CBD) and tetrahydrocannabinol (THC), have been proposed as potential treatments for an…